BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Immunology

Full-Life Technologies Secures $571.5M Licensing Deal with SK Biopharmaceuticals for Anti-Cancer Radiopharmaceutical FL-091

Full-Life Technologies seals $571.5 million agreement with SK Biopharmaceuticals to license and further develop Full-Life's 'FL-091' ra...

September 19, 2024 | News

Massive Bio Launches Free AI-Powered Portal to Simplify Cancer Clinical Trial Enrollment for Patients Worldwide

Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovati...

September 17, 2024 | News

Johnson & Johnson’s TAR-200 Shows Promising Results in BCG-Unresponsive Bladder Cancer in Latest Phase 2b SunRISe-1 Study

Johnson & Johnson announced additional results from its pivotal Phase 2b SunRISe-1 study, reinforcing the safety and efficacy of TAR-200, an investigat...

September 16, 2024 | News

Qritive Partners with Roche to Transform Cancer Diagnostics with AI-Powered Pathology Solutions

Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest ...

September 13, 2024 | News

GC Cell Partners with Indonesia’s Bifarma in Major Technology Transfer for Immuncell-LC Cancer Therapy

GC Cell, a leading innovator in cell therapy, has officially announced the execution of a landmark 'Technology Transfer and License Agreement' with PT Bifa...

September 11, 2024 | News

A. Menarini Diagnostics and Nucleix Partner for Non-Invasive Bladder Cancer Test in Europe

Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe&...

September 10, 2024 | News

Arsenal Biosciences Closes $325 Million Series C Funding to Advance Next-Gen CAR T-Cell Therapies for Solid Tumors

Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid t...

September 05, 2024 | News

Albatroz Therapeutics Joins Johnson & Johnson Innovation – JLABS Singapore to Accelerate Cancer Therapy Development

Albatroz Therapeutics, a biotechnology company developing novel therapies against cancer and other indications, today announced its membership of Johnson &...

September 04, 2024 | News

Acepodia Partners with Pfizer Ignibiolote to Advance Cell Therapies for Autoimmune Diseases and Oncology

Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyon...

September 04, 2024 | News

Jacobio Pharma Grants China Rights for KRAS G12C and SHP2 Inhibitors to Shanghai Allist in Landmark Deal

Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that it has granted the China ...

September 02, 2024 | News

HKBU Research Identifies Phosphocholine as a Potential Therapy for PM2.5-Related Lung Damage

A research team led by Hong Kong Baptist University (HKBU) has discovered that phosphocholine, an important component in the body's metabolism, c...

August 28, 2024 | News

CanariaBio Completes Enrollment for Phase 2 Study of Oregovomab with Chemotherapy in Advanced Ovarian Cancer

CanariaBio Inc, a leading late-stage biotechnology company, announces the successful completion of enrollment of 88 patients in a randomized Phase 2 study ...

August 26, 2024 | News

Everest Medicines Launches First Clinical Trial for Personalized mRNA Cancer Vaccine EVM16 in China

Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeut...

August 22, 2024 | News

GE HealthCare and Roche Diagnostics Partner to Transform Precision Cancer Care in Asia Pacific

GE HealthCare and Roche Diagnostics have entered into a Memorandum of Understanding (MOU) that will leverage the strengths and resources of both comp...

August 22, 2024 | News

Stay Connected